Abstract
Intraventricular hemorrhage (IVH) is defined as the eruption of blood in the cerebral ventricular system and is mostly secondary to spontaneous intracerebral hemorrhage and aneurysmal and arteriovenous malformation rupture. IVH is a proven risk factor of increased mortality and poor functional outcome. Its seriousness is correlated not only with the amount of blood but also with the involvement of the third and fourth ventricles. There are four mechanisms that explain the pathophysiology of this event: acute obstructive hydrocephalus, the mass effect exerted by the blood clot, the toxicity of blood-breaking products on the adjacent brain parenchyma, and, lastly, the development of a chronic hydrocephalus. It is thus obvious that the clearance of blood from the ventricles should be a therapeutic goal. In cases of acute hydrocephalus, external ventricular drainage is a mandatory step, but proven often insufficient. The concomitant use of intraventricular fibrinolytics such as recombinant tissue plasminogen activator or urokinase seems to be beneficial at least in the context of spontaneous intracerebral hemorrhage, in which their use is now accepted but not yet validated by a randomized trial. Given the potential neurotoxicity of these agents, further research is needed in order to identify the best treatment for intraventricular fibrinolysis (IVF). The endoscopic retrieval of intraventricular blood was also described recently and seems to be as efficient as IVF, but its use is limited to specialized centers. IVH represents a therapeutic challenge for neurosurgeons, neurologists, and intensivists. Thus, a better understanding of this dramatic event will help in better tailoring the treatment strategies.
Similar content being viewed by others
References
Almairac F, Litrico S, Fontaine D, Lonjon M, Paquis P (2011) Evaluation of intraventricular thrombolysis for severe intraventricular hemorrhage after aneurysmal rupture: a prospective randomized study. Paper presented at the 4th World ICH conference 2011, World Federation of Neurosurgical Societies and European Associations of Neurosurgery, Newcastle, UK, 3 May 2011
Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN et al (2011) American Heart Association. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40:994–1025 (review)
Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD (2006) Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the stitch trial. Acta Neurochir Suppl 96:65–68
Chen CC, Liu CL, Tung YN, Lee HC, Chuang HC, Lin SZ et al (2011) Endoscopic surgery for intraventricular hemorrhage (IVH) caused by thalamic hemorrhage: comparisons of endoscopic surgery and external ventricular drainage (EVD) surgery. World Neurosurg 75:264–268
Chen Z, Gao C, Hua Y, Keep RF, Muraszko K, Xi G (2011) Role of iron in brain injury after intraventricular hemorrhage. Stroke 42:465–470
Cheung RTF, Zou LY (2003) Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage. Stroke 34:1717–1722
Daverat P, Castel JP, Dartigues JF, Orgogozo JM (1991) Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 22:1–6
Diringer MN, Edwards DF, Zazulia AR (1998) Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 29:1352–1357
Ducruet AF, Hickman ZL, Zacharia BE, Grobelny BT, Narula R, Guo KH et al (2010) Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage. Neurosurgery 66:648–655
Findlay JM, Jacka MJ (2004) Cohort study of intraventricular thrombolysis with recombinant tissus plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery 55:532–537
Flint AC, Roebken A, Singh V (2008) Primary intraventricular hemorrhage: yield of diagnostic angiography and clinical outcome. Neurocrit Care 8:330–336
Franke CL, van Swieten JC, Algra A, van Gijn J (1992) Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry 55:653–657
Gaberel T, Magheru C, Parienti JJ, Huttner HB, Vivien D, Emery E (2011) Intraventricular fibrinolysis versus external ventricular drainage alone in intraventricular hemorrhage: a meta-analysis. Stroke 42:2776–2781
Gaberel T, Emery E, Vivien D (2011) Letter by Gaberel et al. regarding article, “Dose effect of intraventricular fibrinolysis in ventricular hemorrhage”. Stroke 42:e548–e549 (letter)
Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB (1982) Computed tomographic diagnosis of intraventricular hemorrhage. Etiology and prognosis. Radiology 143:91–96
Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin-Schild S, Khaja AM et al (2008) Intraventricular hemorrhage. Anatomic relationships and clinical implications. Neurology 70:848–852
Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC (2001) The ich score: a simple reliable grading scale for intracerebral hemorrhage. Stroke 32:891–897
Hinson HE, Melnychuk E, Muschelli J, Hanley DF, Awad IA, Ziai WC (2012) Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care 16:399–405
Komatsu F, Komatsu M, Wakuta N, Oshiro S, Tsugu H, Iwaasa M et al (2010) Comparison of clinical outcomes of intraventricular hematoma between neuroendoscopic removal and extraventricular drainage. Neurol Med Chir (Tokyo) 50:972–976
LaPointe M, Haines S (2002) Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD003692. doi:10.1002/14651858.CD003692
Liberatore GT, Samson A, Bladin C, Schleuning WD, Medcalf RL (2003) Vampire bat salivary plasminogen activator (Desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke 34:537–543
Little JR, Blomquist GA Jr, Ethier R (1977) Intraventricular hemorrhage in adults. Surg Neurol 8:143–149
Lodhia KR, Shakui P, Keep RF (2006) Hydrocephalus in a rat model of intraventricular hemorrhage. Acta Neurochir Suppl 96:207–211
Longatti PL, Martinuzzi A, Fiorindi A, Maistrello L, Carteri A (2004) Neuroendoscopic management of intraventricular hemorrhage. Stroke 35:e35–e38
Longatti P, Fiorindi A, Di Paola F, Curtolo S, Basaldella L, Martinuzzi A (2006) Coiling and neuroendoscopy: a new perspective in the treatment of intraventricular haemorrhages due to bleeding aneurysms. J Neurol Neurosurg Psychiatry 77:1354–1358
Marti Fabregas J, Belvis R, Guardia E, Cocho D, Munoz J, Marruecos L et al (2003) Neurology 61:1051–1056
Masè G, Zorzon M, Biasutti E, Tasca G, Vitrani B, Cazzato G (1995) Immediate prognosis of primary intracerebral hemorrhage using an easy model for the prediction of survival. Acta Neurol Scand 91:306–309
Mayfrank L, Kissler J, Raoofi R, Delsing P, Weis J, Küker W et al (1997) Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment. Stroke 28:141–148
Mohr G, Ferguson G, Khan M, Malloy D, Watts R, Benoit B et al (1983) Intraventricular hemorrhage from ruptured aneurysm. J Neurosurg 58:482–487
Morgan T, Awad I, Keyl P, Lane K, Hanley D (2008) Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl 105:217–220
Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, The American Heart Association Stroke Council and Council on Cardiovascular Nursing et al (2010) Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 41:2108–2129
Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA (2011) Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke 42:3009–3016
Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET et al (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7:59–64
Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A (2000) Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol 247:117–121 (review)
Nishikawa T, Ueba T, Kajiwara M, Miyamatsu N, Yamashita K (2009) A priority treatment of the intraventricular hemorrhage (IVH) should be performed in the patients suffering intracerebral hemorrhage with large IVH. Clin Neurol Neurosurg 111:450–453
Nomura S, Ishihara H, Yoneda H, Shirao S, Shinoyama M, Suzuki M (2010) Neuroendoscopic evacuation of intraventricular hematoma associated with thalamic hemorrhage to shorten the duration of external ventricular drainage. Surg Neurol Int 1:43–49
Oertel JM, Mondorf Y, Baldauf J, Schroeder HW, Gaab MR (2009) Endoscopic third ventriculostomy for obstructive hydrocephalus due to intracranial hemorrhage with intraventricular extension. J Neurosurg 111:1119–1126
Ozdemir O, Calisaneller T, Hasturk A, Aydemir F, Caner H, Altinors N (2008) Prognostic significance of third ventricle dilation in spontaneous intracerebral hemorrhage: a preliminary clinical study. Neurol Res 30:406–410
Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model: part 1. Canine intraventricular blood cast model. Neurosurgery 19:540–546
Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model: part 2. In vivo safety study of intraventricular urokinase. Neurosurgery 19:547–552
Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model: part 3. Effect of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 19:553–572
Qureshi AI, Safdar K, Weil J (1995) Predictors of early deterioration and mortality in Black Americans with spontaneous intracerebral hemorrhage. Stroke 26:1764–1767
Ramakrishna R, Sekhar LN, Ramanathan D, Temkin N, Hallam D, Ghodke BV et al (2010) Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 67:110–117
Razzaq AA, Hussain R (1998) Determinants of 30-day mortality of spontaneous intracerebral hemorrhage in Pakistan. Surg Neurol 50:336–343
Ritschl E, Auer LM (1987) Endoscopic evacuation of an intracerebral and intraventricular haemorrhage. Arch Dis Child 62:1163–1181
Rohde V, Rohde I, Thiex R, Ince A, Jung A, Dückers G et al (2002) Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg 97:954–962
Shapiro AS, Campbell RL, Scully T (1994) Hemorrhagic dilation of the fourth ventricle: an ominous predictor. J Neurosurg 80:805–809
Shen PH, Matsuoka Y, Kawajiri K, Kanai M, Hoda K, Yamamoto S et al (1990) Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir (Tokyo) 30:329–333
Staykov D, Huttner HB, Struffert T, Ganslandt O, Doerfler A, Schwab S et al (2009) Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage. Stroke 40:3275–3280
Staykov D, Huttner HB, Lunkenheimer J, Volbers B, Struffert T, Doerfler A et al (2010) Single versus bilateral external ventricular drainage for intraventricular fibrinolysis in severe ventricular haemorrhage. J Neurol Neurosurg Psychiatry 81:105–108
Staykov D, Volbers B, Wagner I, Huttner HB, Doerfler A, Schwab S et al (2011) Prognostic significance of third ventricle blood volume in intracerebral haemorrhage with severe ventricular involvement. J Neurol Neurosurg Psychiatry 82:1260–1263
Staykov D, Wagner I, Volbers B, Huttner HB, Doerfler A, Schwab S et al (2011) Dose effect of intraventricular fibrinolysis in ventricular hemorrhage. Stroke 42:2061–2064
Takahashi O, Cook EF, Nakamura T, Saito J, Ikawa F, Fukui T (2006) Risk stratification for in-hospital mortality in spontaneous intracerebral hemorrhage: a classification and regression tree analysis. Q J Med 99: 743–750
Torres A, Plans G, Martino J, Godino O, Garcia I, Gracia B et al (2008) Fibrinolytic therapy in spontaneous intraventricular haemorrhage: efficacy and safety of the treatment. Br J Neurosurg 22:269–274
Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17:543–552
Tuhrim S, Horowitz DR, Sacher M, Godbold JH (1999) Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 27:617–621
Varelas N, Rickert KL, Cusick J (2005) Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery 56:205–213
Wang YC, Lin CW, Shen CC, Lai SC, Kuo JS (2002) Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose–effect relationship. J Neurol Sci 202:35–41
Xi G, Keep RF, Hoff JT (2006) Mechanisms of brain injury after intracerebral hemorrhage. Lancet Neurol 5:53–63
Yadav YR, Mukerji G, Shenoy R, Basoor A, Jain G, Nelson A (2007) Endoscopic management of hypertensive intraventricular haemorrhage with obstructive hydrocephalus. BMC Neurol 7:1–9
Yepes M, Roussel BD, Ali C, Vivien D (2008) Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci 32:48–55
Zhang Z, Li X, Liu Y, Shao Y, Xu S, Yang Y (2007) Application of neuroendoscopy in the treatment of intraventricular hemorrhage. Cerebrovasc Dis 24:91–96
Acknowledgments
The authors thank Miss Apollonia Annang for her assistance in English corrections and Keven Ponte for his computing assistance.
Sources of funding
None.
Conflicts of interest/disclosures
The authors declare that they have no conflict of interest or financial disclosure.
Author information
Authors and Affiliations
Corresponding author
Additional information
Comments
Dattatraya Muzumdar, Mumbai, India
Gaberel et al. present a review on non-traumatic intraventricular hemorrhage and discuss the pathophysiology and management in detail.
Intraventricular hemorrhage is a serious condition which can result in enhanced morbidity and mortality. The bleeding is deep-seated and causes obstructive hydrocephalus. The management protocols are diverse and the outcomes are not universally uniform, ranging from severe morbidity to imminent mortality.
The manuscript is well written and discussed. It covers a wide range of reports in the literature and presents them in a concise manner. This would serve as a marker for future research and randomized controlled studies in this difficult to “understand and manage” condition. Quality of life studies evaluating the improvement in higher functions and integration of the patient into the society would be helpful.
Joachim Oertel and Guilherme Ramina Montibeller, Homburg/Saar, Germany
Gaberel et al. undertook the difficult task of summarizing a subject where no or only very little evidence exist. They report on the optimal treatment strategy for non-traumatic intraventricular hemorrhage (IVH).
IVH is a common situation in neurosurgery with frequent guarded prognosis and a high mortality rate. It can occur primarily or secondary to intraparenchymal or subarachnoid hemorrhage. The combination of intracerebral hemorrhage or subarachnoid hemorrhage and blood in the ventricles is associated with a poor outcome [1, 3, 4, 6]. There are still great controversies about the treatment of this pathology, from the clinical management to the indication of surgery. The development of hydrocephalus after hemorrhage in ventricles is not uncommon, and the ideal surgical intervention is still under debate. External ventricular drainage, intraventricular fibrinolysis, and endoscopic third ventriculostomy are some of the possibilities.
The most frequent treatment of intraventricular hemorrhage is ventricular drainage, with or without fibrinolysis. Because of frequent clotting of the external ventricular drains and the need of recurrent exchanges, the management of this condition is frequently awkward. The idea of an endoscopic intraventricular operation, when clear vision is of utmost important, seems at first sight out of question. Neuroendoscopic experience in intraventricular hemorrhage is rarely described in the literature. Longatti et al. reported the treatment of IVH with the neuroendoscope in 13 cases over a period of 7 years [5]. A flexible endoscope was used, and the clinical outcome was evaluated. A good amount of intraventricular blood could be removed in all patients. This series of cases was small, but the results indicated that a rigid endoscope could provide a superior intraventricular view with better possibilities. Chen et al. compared the endoscopic surgery and external ventricular drainage for intraventricular hemorrhage caused by thalamic hemorrhage [1]. The outcome and mortality rate where not significantly different between the two groups. Nevertheless, in the endoscopic surgery group, the need of a ventricular shunt was importantly lower, and the intensive care unit stay was shorter. In 2009, our group published a study reporting the experience of endoscopic third ventriculostomy performed by hemorrhage-related obstructive hydrocephalus in 34 patients [7]. Based on the results, endoscopic third ventriculostomy can be considered a valuable treatment option, especially in patients with predominant cerebrospinal fluid obstruction and lack of a large space-occupying hemorrhage.
In all, the optimal treatment of IVH remains still unclear. However, numerous studies have been published which demonstrate a beneficial effect of a more aggressive surgical therapy than just external drain placement. The presented manuscript of Gaberel et al., from the University Hospital of Caen, Management of Non-traumatic Intraventricular Hemorrhage, reviews the etiology, the prognostic factors, and the classification of this disease. The group discusses the pathophysiology and the various opinions of the current debate. The paper evaluates the various aspects of the treatment decision. Nevertheless, randomized studies should give us evidence that a more aggressive treatment provides superior results before more definite conclusions can be made [8].
References
[1] Chen CC, Liu CL, Tung YN, Lee HC, Chuang HC, Lin SZ, Cho DY (2011) Endoscopic surgery for intraventricular hemorrhage (IVH) caused by thalamic hemorrhage: comparisons of endoscopic surgery and external ventricular drainage (EVD) surgery. World Neurosurg 75(2):264–8
[2] Gaberel T, Emery E, Vivien D (2011) Letter by Gaberel et al. regarding article, “Dose effect of intraventricular fibrinolysis in ventricular hemorrhage. Stroke 42(9):e548–9; author reply e550 (E-pub 4 Aug 2011)
[3] Giray S, Sen O, Sarica FB, Tufan K, Karatas M, Goksel BK, Yerdelen D, Cekinmez M, Can U (2009) Spontaneous primary intraventricular hemorrhage in adults: clinical data, etiology and outcome. Turk Neurosurg 19(4):338–344
[4] Komatsu F, Komatsu M, Wakuta N, Oshiro S, Tsugu H, Iwaasa M, Inoue T (2010) Comparison of clinical outcomes of intraventricular hematoma between neuroendoscopic removal and extraventricular drainage. Neurol Med Chir (Tokyo) 50(11):972–976
[5] Longatti PL, Martinuzzi A, Fiorindi A, Maistrello L, Carteri A (2004) Neuroendoscopic management of intraventricular hemorrhage. Stroke 35(2):e35–8 (E-pub 22 Jan 2004)
[6] Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A (2000) Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol 247(2):117–121
[7] Oertel JM, Mondorf Y, Baldauf J, Schroeder HW, Gaab MR (2009) Endoscopic third ventriculostomy for obstructive hydrocephalus due to intracranial hemorrhage with intraventricular extension. J Neurosurg 111(6):1119–1126
[8] Vulcu S, Oertel J (2011) Therapy of obstructive hydrocephalus due to intraventricular hemorrhage: is there a need for neuroendoscopy? Neurol India 59(6):846–847
Rights and permissions
About this article
Cite this article
Gaberel, T., Magheru, C. & Emery, E. Management of non-traumatic intraventricular hemorrhage. Neurosurg Rev 35, 485–495 (2012). https://doi.org/10.1007/s10143-012-0399-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-012-0399-9